Stock Detail
Videos
Shuttle Pharma (SHPH) Fireside Chat
During this fireside chat we welcome Shuttle Pharma (Nasdaq: SHPH). Shuttle Pharma is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). This fireside chat was...
Shuttle Pharma (SHPH) Company Webcast
During this presentation we welcome, Shuttle Pharma. Shuttle Pharma (Nasdaq: SHPH) is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). The Company's mission is...
Shuttle Pharmaceuticals (SHPH) Company Webcast
During this presentation, we welcome Shuttle Pharmaceuticals. Shuttle is traded on the Nasdaq under the symbol SHPH. And joining us today from the company is Dr. Anatoly Dritschilo, the company's Chairman and CEO. Founded in 2012 by faculty members of the Georgetown...
News
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
GAITHERSBURG, Md., March 13, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT),...
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
GAITHERSBURG, Md., March 12, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT),...
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities
Dr. Anatoly Dritschilo remains Chairman of the Board and Co-CEO overseeing scientific and clinical trial activitiesGAITHERSBURG, Md., March 12, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and...